Biotech companies by short interest

Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.

BioNTech has the lowest figure of the 24 biotech companies ranked by short interest, at 0.91%, followed by Gilead Sciences (1.72%) and argenx (2.25%). Figures as of the 30 Oct 2026 settlement date, from FINRA's short interest report, with shares outstanding from Yahoo Finance quotes.

Key facts

Companies ranked
24
Lowest
BioNTech0.91%
Median
9.33%
Combined market value
CHF 709.9B
Countries
5

Market values as of .

All countries
All sectors
Biotech
CHF
Clear filters
Biotech companies by short interest
#CompanyShort interest % ↑Market capPriceToday1 yearPrice, 30 daysCountry
1BioNTechBNTX · Health Care0.91%CHF 17.6BCHF 70.92 0.81% down 16% down Germany
2Gilead SciencesGILD · Health Care1.72%CHF 177.1BCHF 142.81 0.45% down 33% up United States
3argenxARGX · Health Care2.25%CHF 50.1BCHF 797.16 0.15% down 4% up Belgium
4AmgenAMGN · Health Care2.33%CHF 203.8BCHF 376.81 2.34% down 34% up United States
5QiagenQGEN · Health Care3.10%CHF 8.6BCHF 41.82 0.24% down 12% up Netherlands
6BiogenBIIB · Health Care3.69%CHF 31.4BCHF 212.35 0.49% up 49% up United States
7Bio-TechneTECH · Health Care4.90%CHF 9.6BCHF 61.33 0.21% up 26% up United States
8Neurocrine BiosciencesNBIX · Health Care5.83%CHF 13.9BCHF 137.06 1.96% down 20% up United States
9Revolution MedicinesRVMD · Health Care6.05%CHF 29.1BCHF 134.43 1.93% down 131% up United States
10Adaptive BiotechnologiesADPT · Health Care7.09%CHF 3.9BCHF 24.15 0.60% up 88% up United States
11ModernaMRNA · Health Care8.20%CHF 69BCHF 170.42 2.20% down 755% up United States
12ImmunovantIMVT · Health Care8.96%CHF 5.8BCHF 28.25 0.96% up 43% up United States
13VaxcytePCVX · Health Care9.70%CHF 7.9BCHF 49.59 0.92% down 22% up United States
14Kymera TherapeuticsKYMR · Health Care9.84%CHF 8.8BCHF 103.08 0.67% up 87% up United States
15Krystal BiotechKRYS · Health Care10.3%CHF 7.8BCHF 264.18 5.02% up 46% up United States
16CG OncologyCGON · Health Care10.3%CHF 6.1BCHF 68.82 3.47% up 85% up United States
17ExelixisEXEL · Health Care10.5%CHF 14.2BCHF 58.33 1.06% up 63% up United States
18RepligenRGEN · Health Care11.0%CHF 9.3BCHF 145.28 6.32% up 5% up United States
19ImmunityBioIBRX · Health Care11.9%CHF 6BCHF 5.67 7.51% up 193% up United States
20Halozyme TherapeuticsHALO · Health Care12.0%CHF 9.3BCHF 81.34 0.59% up 37% up United States
21Kodiak SciencesKOD · Health Care12.4%CHF 5.4BCHF 82.08 0.64% up 396% up United States
22Twist BioscienceTWST · Health Care14.4%CHF 6.8BCHF 99.20 5.12% up 340% up United States
23CRISPR TherapeuticsCRSP · Health Care17.7%CHF 3.4BCHF 35.47 4.86% up 21% down Switzerland
24Scholar Rock HoldingSRRK · Health Care19.2%CHF 4.9BCHF 39.88 5.00% up 14% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; short interest from FINRA, the owner and source of the data, as of the 30 Oct 2026 settlement date.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Source: FINRA. Short interest is the shares sold short and not yet covered as brokers reported them to FINRA for the 30 Oct 2026 settlement date; FINRA publishes it about seven business days later, so it is not today's figure. It is divided by shares outstanding worked out as the market value over the share price, both from the same quote — not by the float, so the percent reads lower than a percent of float would. For a company with more than one class of shares the market value covers every class, which lowers it further. Sums are converted from US dollars at today's exchange rate (1 USD = 0.8426 CHF).

Questions and answers

Which biotech companies have the lowest short interest?

BioNTech (0.91%), Gilead Sciences (1.72%) and argenx (2.25%) have the lowest short interest of the 24 biotech companies ranked here as of the 30 Oct 2026 settlement date.

How many biotech companies are in this ranking?

24 are ranked by short interest.

What are these biotech companies worth together?

The 24 biotech companies ranked by short interest have a combined market value of CHF 709.9B as of the 30 Oct 2026 settlement date.

What does ranking by short interest measure?

Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.

Cite this page

Funkfolio, “Biotech companies by short interest”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=short-interest

Underlying data: FINRA short interest (the 30 Oct 2026 settlement date); Yahoo Finance.